{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:38:00Z","timestamp":1792633080946,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-024-05202-2","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T04:41:00Z","timestamp":1731645660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Different antithrombotic strategies to prevent cardiovascular complications in Kawasaki patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Ramin","family":"Assempoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza Sattari","family":"Abroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Azarboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Ghaseminejad-Raeini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"issue":"3","key":"5202_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_1_19","volume":"20","author":"AS Sheikh","year":"2019","unstructured":"Sheikh AS, Hailan A, Kinnaird T, Choudhury A, Smith D. Coronary Artery Aneurysm: Evaluation, Prognosis, and Proposed Treatment Strategies. Heart Views. 2019;20(3):101\u20138.","journal-title":"Heart Views"},{"key":"5202_CR2","doi-asserted-by":"crossref","unstructured":"Abou Sherif S, Ozden Tok O, Ta\u015fk\u00f6yl\u00fc \u00d6, Goktekin O, Kilic ID: Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment. Frontiers in Cardiovascular Medicine 2017, 4.","DOI":"10.3389\/fcvm.2017.00024"},{"key":"5202_CR3","doi-asserted-by":"crossref","unstructured":"Kawsara A, Gil IJN, Alqahtani F, Moreland J, Rihal CS, Alkhouli M: Management of Coronary\u00a0Artery\u00a0Aneurysms. JACC: Cardiovascular Interventions 2018, 11(13):1211\u20131223.","DOI":"10.1016\/j.jcin.2018.02.041"},{"key":"5202_CR4","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.injr.2015.07.010","volume":"10","author":"D Sharma","year":"2015","unstructured":"Sharma D, Singh S. Kawasaki disease - A common childhood vasculitis. Indian J Rheumatol. 2015;10:S78-s83.","journal-title":"Indian J Rheumatol"},{"issue":"6","key":"5202_CR5","first-page":"365","volume":"91","author":"A Saguil","year":"2015","unstructured":"Saguil A, Fargo M, Grogan S. Diagnosis and management of kawasaki disease. Am Fam Physician. 2015;91(6):365\u201371.","journal-title":"Am Fam Physician"},{"issue":"12","key":"5202_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/jamapediatrics.2016.2055","volume":"170","author":"S Chen","year":"2016","unstructured":"Chen S, Dong Y, Kiuchi MG, Wang J, Li R, Ling Z, Zhou T, Wang Z, Martinek M, P\u00fcrerfellner H, et al. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention\u202f: A Systematic Review and Meta-analysis. JAMA Pediatr. 2016;170(12):1156\u201363.","journal-title":"JAMA Pediatr"},{"issue":"8","key":"5202_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrrheum.2015.54","volume":"11","author":"ST Shulman","year":"2015","unstructured":"Shulman ST, Rowley AH. Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol. 2015;11(8):475\u201382.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"5202_CR8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00431-019-03368-x","volume":"178","author":"R Tanoshima","year":"2019","unstructured":"Tanoshima R, Hashimoto R, Suzuki T, Ishiguro A, Kobayashi T. Effectiveness of antiplatelet therapy for Kawasaki disease: a systematic review. Eur J Pediatr. 2019;178(6):947\u201355.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"5202_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","volume":"21","author":"E Bosco","year":"2021","unstructured":"Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021;21(1):241.","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"5202_CR10","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, G\u00f8tzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12(12):1500\u201324.","journal-title":"Int J Surg"},{"issue":"4","key":"5202_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/0091217415589306","volume":"49","author":"XL Cao","year":"2015","unstructured":"Cao XL, Zhong BL, Xiang YT, Ungvari GS, Lai KY, Chiu HF, Caine ED. Prevalence of suicidal ideation and suicide attempts in the general population of China: A meta-analysis. Int J Psychiatry Med. 2015;49(4):296\u2013308.","journal-title":"Int J Psychiatry Med"},{"key":"5202_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1745-6215-11-32","volume":"11","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11:32.","journal-title":"Trials"},{"issue":"7109","key":"5202_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"3","key":"5202_CR14","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","volume":"74","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785\u201394.","journal-title":"Biometrics"},{"issue":"9","key":"5202_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/BF02190688","volume":"153","author":"S Furukawa","year":"1994","unstructured":"Furukawa S, Matsubara T, Umezawa Y, Motohashi T, Ino T, Yabuta K. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease. Eur J Pediatr. 1994;153(9):663\u20137.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"5202_CR16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1442-200X.1991.tb02611.x","volume":"33","author":"K Furusho","year":"1991","unstructured":"Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, et al. Intravenous gamma-globulin for Kawasaki disease. Acta Paediatr Jpn. 1991;33(6):799\u2013804.","journal-title":"Acta Paediatr Jpn"},{"key":"5202_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2431-14-27","volume":"14","author":"Y Inamo","year":"2014","unstructured":"Inamo Y, Saito K, Hasegawa M, Hayashi R, Nakamura T, Abe O, Ishikawa T, Yoshino Y, Hashimoto K, Fuchigami T. Effect of dalteparin, a low-molecular-weight heparin, as adjunctive therapy in patients with Kawasaki disease: a retrospective study. BMC Pediatr. 2014;14:27.","journal-title":"BMC Pediatr"},{"issue":"2","key":"5202_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00431-022-04719-x","volume":"182","author":"Y Koyama","year":"2023","unstructured":"Koyama Y, Miura M, Kobayashi T, Hokosaki T, Suganuma E, Numano F, Furuno K, Shiono J, Ebata R, Fuse S, et al. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement. Eur J Pediatr. 2023;182(2):633\u201340.","journal-title":"Eur J Pediatr"},{"issue":"11","key":"5202_CR19","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1177\/0009922814566932","volume":"54","author":"N Michihata","year":"2015","unstructured":"Michihata N, Matsui H, Fushimi K, Yasunaga H. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm. Clin Pediatr (Phila). 2015;54(11):1076\u201380.","journal-title":"Clin Pediatr (Phila)"},{"issue":"3","key":"5202_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1253\/circj.69.265","volume":"69","author":"Z Onouchi","year":"2005","unstructured":"Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, Itoi T, Kiyosawa N. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens. Circ J. 2005;69(3):265\u201372.","journal-title":"Circ J"},{"issue":"7","key":"5202_CR21","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1253\/circj.CJ-08-0931","volume":"73","author":"K Suda","year":"2009","unstructured":"Suda K, Kudo Y, Higaki T, Nomura Y, Miura M, Matsumura M, Ayusawa M, Ogawa S, Matsuishi T. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ J. 2009;73(7):1319\u201323.","journal-title":"Circ J"},{"issue":"2","key":"5202_CR22","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00246-007-9132-9","volume":"29","author":"Y Sugahara","year":"2008","unstructured":"Sugahara Y, Ishii M, Muta H, Iemura M, Matsuishi T, Kato H. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol. 2008;29(2):398\u2013401.","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"5202_CR23","first-page":"928","volume":"32","author":"DM Levy","year":"2005","unstructured":"Levy DM, Silverman ED, Massicotte MP, McCrindle BW, Yeung RS. Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease. J Rheumatol. 2005;32(5):928\u201334.","journal-title":"J Rheumatol"},{"key":"5202_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijcard.2020.07.022","volume":"321","author":"T Low","year":"2020","unstructured":"Low T, Jegatheeswaran A, Devlin PJ, Chahal N, Brand\u00e3o LR, McCrindle BW. Bleeding risk associated with combination thromboprophylaxis therapy is low for patients with coronary artery aneurysms after Kawasaki disease. Int J Cardiol. 2020;321:6\u201311.","journal-title":"Int J Cardiol"},{"issue":"6","key":"5202_CR25","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s00246-010-9715-8","volume":"31","author":"C Manlhiot","year":"2010","unstructured":"Manlhiot C, Brand\u00e3o LR, Somji Z, Chesney AL, MacDonald C, Gurofsky RC, Sabharwal T, Chahal N, McCrindle BW. Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities. Pediatr Cardiol. 2010;31(6):834\u201342.","journal-title":"Pediatr Cardiol"},{"issue":"10","key":"5202_CR26","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.cjca.2020.01.016","volume":"36","author":"C Manlhiot","year":"2020","unstructured":"Manlhiot C, Newburger JW, Low T, Dahdah N, Mackie AS, Raghuveer G, Giglia TM, Dallaire F, Mathew M, Runeckles K, et al. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial. Can J Cardiol. 2020;36(10):1598\u2013607.","journal-title":"Can J Cardiol"},{"key":"5202_CR27","doi-asserted-by":"crossref","unstructured":"Kwon JE, Roh DE, Kim YH: The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic Acid. Children (Basel) 2020, 7(10).","DOI":"10.3390\/children7100185"},{"issue":"3","key":"5202_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4070\/kcj.2013.43.3.182","volume":"43","author":"G Lee","year":"2013","unstructured":"Lee G, Lee SE, Hong YM, Sohn S. Is high-dose aspirin necessary in the acute phase of kawasaki disease? Korean Circ J. 2013;43(3):182\u20136.","journal-title":"Korean Circ J"},{"key":"5202_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fped.2019.00121","volume":"7","author":"YH Huang","year":"2019","unstructured":"Huang YH, Lin KM, Ho SC, Yan JH, Lo MH, Kuo HC. Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study. Front Pediatr. 2019;7:121.","journal-title":"Front Pediatr"},{"issue":"8","key":"5202_CR30","first-page":"801","volume":"21","author":"YL Liu","year":"2019","unstructured":"Liu YL, Wang XM, Chen TT, Shi K, Lu YH, Guo YH, Li Y. Clinical effect and safety of clopidogrel combined with aspirin in antithrombotic therapy for children with Kawasaki disease complicated by small\/medium-sized coronary artery aneurysms. Zhongguo Dang Dai Er Ke Za Zhi. 2019;21(8):801\u20135.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"5202_CR31","first-page":"649","volume":"28","author":"YDZ Zheng","year":"2013","unstructured":"Zheng YDZ. Warfarin and aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease. Chin J Appl Clin Pediatr. 2013;28:649\u201352.","journal-title":"Chin J Appl Clin Pediatr"},{"issue":"11","key":"5202_CR32","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.amjcard.2010.01.332","volume":"105","author":"RT McCandless","year":"2010","unstructured":"McCandless RT, Minich LL, Tani LY, Williams RV. Does abciximab promote coronary artery remodeling in patients with Kawasaki disease? Am J Cardiol. 2010;105(11):1625\u20138.","journal-title":"Am J Cardiol"},{"issue":"1","key":"5202_CR33","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1542\/peds.109.1.e4","volume":"109","author":"RV Williams","year":"2002","unstructured":"Williams RV, Wilke VM, Tani LY, Minich LL. Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics. 2002;109(1):E4.","journal-title":"Pediatrics"},{"issue":"12","key":"5202_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144603","volume":"10","author":"HC Kuo","year":"2015","unstructured":"Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease. PLoS ONE. 2015;10(12): e0144603.","journal-title":"PLoS ONE"},{"issue":"2","key":"5202_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/apc.APC_206_20","volume":"14","author":"F Sanati","year":"2021","unstructured":"Sanati F, Bagheri M, Eslami S, Khalooei A. Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm. Ann Pediatr Cardiol. 2021;14(2):146\u201351.","journal-title":"Ann Pediatr Cardiol"},{"issue":"6","key":"5202_CR36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/jhg.2013.40","volume":"58","author":"MT Lee","year":"2013","unstructured":"Lee MT, Klein TE. Pharmacogenetics of warfarin: challenges and opportunities. J Hum Genet. 2013;58(6):334\u20138.","journal-title":"J Hum Genet"},{"issue":"8","key":"5202_CR37","volume":"14","author":"K Rajasekaran","year":"2022","unstructured":"Rajasekaran K, Duraiyarasan S, Adefuye M, Manjunatha N, Ganduri V. Kawasaki Disease and Coronary Artery Involvement: A Narrative Review. Cureus. 2022;14(8): e28358.","journal-title":"Cureus"},{"key":"5202_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.738850","volume":"8","author":"P Buda","year":"2021","unstructured":"Buda P, Friedman-Gruszczy\u0144ska J, Ksi\u0105\u017cyk J. Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives. Front Med (Lausanne). 2021;8: 738850.","journal-title":"Front Med (Lausanne)"},{"key":"5202_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fped.2020.00249","volume":"8","author":"Y Ito","year":"2020","unstructured":"Ito Y, Matsui T, Abe K, Honda T, Yasukawa K, Takanashi JI, Hamada H. Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan. Front Pediatr. 2020;8:249.","journal-title":"Front Pediatr"},{"key":"5202_CR40","doi-asserted-by":"crossref","unstructured":"Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR et al: Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population. J Am Heart Assoc 2016, 5(9).","DOI":"10.1161\/JAHA.116.003289"},{"issue":"2","key":"5202_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3349\/ymj.2022.0279","volume":"64","author":"N Kang","year":"2023","unstructured":"Kang N, Choi KH, Kim SM, Kim DK, Sung K, Choi DC. Giant Coronary Artery Aneurysm with Thrombosis Complicated in a Patient with Idiopathic Hypereosinophilic Syndrome. Yonsei Med J. 2023;64(2):148\u201351.","journal-title":"Yonsei Med J"},{"issue":"6","key":"5202_CR42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.14503\/THIJ-13-3896","volume":"41","author":"PD Crawley","year":"2014","unstructured":"Crawley PD, Mahlow WJ, Huntsinger DR, Afiniwala S, Wortham DC. Giant coronary artery aneurysms: review and update. Tex Heart Inst J. 2014;41(6):603\u20138.","journal-title":"Tex Heart Inst J"},{"issue":"1","key":"5202_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.acvd.2019.10.008","volume":"113","author":"V Pham","year":"2020","unstructured":"Pham V, Hemptinne Q, Grinda JM, Duboc D, Varenne O, Picard F. Giant coronary aneurysms, from diagnosis to treatment: A literature review. Arch Cardiovasc Dis. 2020;113(1):59\u201369.","journal-title":"Arch Cardiovasc Dis"},{"issue":"1","key":"5202_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000363732","volume":"129","author":"D Su","year":"2014","unstructured":"Su D, Wang K, Qin S, Pang Y. Safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease: a meta-analysis. Cardiology. 2014;129(1):55\u201364.","journal-title":"Cardiology"},{"issue":"7","key":"5202_CR45","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1055\/s-0041-1726096","volume":"47","author":"M Christiansen","year":"2021","unstructured":"Christiansen M, Grove EL, Hvas AM. Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives. Semin Thromb Hemost. 2021;47(7):800\u201314.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"5202_CR46","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1172\/JCI121985","volume":"129","author":"S Lucotti","year":"2019","unstructured":"Lucotti S, Cerutti C, Soyer M, Gil-Bernab\u00e9 AM, Gomes AL, Allen PD, Smart S, Markelc B, Watson K, Armstrong PC, et al. Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1\/thromboxane A2. J Clin Invest. 2019;129(5):1845\u201362.","journal-title":"J Clin Invest"},{"key":"5202_CR47","unstructured":"Patel S, Singh R, Preuss CV, Patel N: Warfarin. In: StatPearls. edn. Treasure Island (FL): StatPearls Publishing. Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05202-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-05202-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05202-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:04:40Z","timestamp":1731650680000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-05202-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5202"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-05202-2","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"3 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"738"}}